The largest database of trusted experimental protocols

490 protocols using quantikine

1

Biomarker Assessment in Cardiovascular Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was drawn from participants concurrent with CMR, and samples were processed for serum and plasma on the same day using standard protocols and stored at − 80 °C until assays were performed. Biomarkers of inflammation (interleukin-6 [IL-6], soluble cluster of differentiation 14 [sCD14], galectin-3), ventricular and cellular stress (N-terminal prohormone of brain natriuretic peptide [NT-proBNP], growth differentiation factor-15 [GDF-15]), tissue remodeling (tissue inhibitor of metalloproteinase-2 [TIMP-2], matrix metalloproteinase-2 [MMP-2]) and tissue injury (high-sensitivity troponin I [hsTnI]) were measured in serum and plasma at central laboratories. Serum levels of IL-6 were measured by electrochemiluminescence (Meso Scale Discovery V-PLEX), and the following markers were measured by enzyme-linked immunosorbent assay: sCD14 (R&D Systems Quantikine), GDF-15 (R&D Systems Quantikine), TIMP-2 (R&D Systems Quantikine), MMP-2 (R&D Systems Quantikine), and NT-proBNP (Abbott Architect i2000sR) in serum, and galectin-3 (Abbott Architect i2000sR) and hsTnI (Abbott Architect i2000sR) in plasma.
+ Open protocol
+ Expand
2

Quantifying Inflammatory Biomarkers in Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The serum level of tumor necrosis factor-alpha (TNF-alpha) was measured in duplicate by using a commercially available enzyme immunoassay (Quantikine, R&D Systems Inc., Minneapolis, USA). The sensitivity of this assay was 2.6 pg/ml, the intra-assay coefficient of variation was ±8.8%, and the interassay coefficient of variation was ±16.7%. In addition, the serum level of soluble TNF-alpha receptor I (sTNFr-I) was quantified by ELISA (Quantikine, R&D Systems Inc.), and the serum level of soluble Fas (sFas) was measured by a sandwich enzyme immunoassay (Quantikine, R&D Systems Inc.). Moreover, sFas ligand (sFas L) was quantified with an immunoassay kit (MBL, Tokyo, Japan). In this immunoassay, concomitant measurement of seven sFas L standards with known concentrations (0.16, 0.31, 0.63, 1.25, 2.5, 5, and 10 ng/ml) was performed together with patient samples and the detection limit for sFas L was <50 pg/ml. Each assay was performed according to the manufacturer's recommendations [18 (link)].
+ Open protocol
+ Expand
3

Biomarkers of Cardiorenal Dysfunction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting venous blood was collected at each visit. Serum creatinine, lipid profile, glycated hemoglobin A1c (HbA1C), and urine albumin to creatinine ratio (ACR) were measured in the local clinical laboratory. Estimated glomerular filtration rate (eGFR) was calculated using the 2009 Chronic Kidney Disease Epidemiology Collaboration creatinine equation (15 (link)). Enzyme-linked immunosorbent assays were performed to measure serum tissue plasminogen activator (Asserachrom, Stago, Reading, United Kingdom), plasminogen activator inhibitor-1 (Asserachrom), von Willebrand factor (vWF) (Asserachrom), and intracellular adhesion molecule (ICAM)-1 (Quantikine, R&D Systems, Abingdon, United Kingdom). Cystatin-C was measured using a particle enhanced turbidimetric immunoassay (Tina-quant, Roche, Germany). Serum high-sensitivity C-reactive protein and lipoprotein(a) were measured (Roche c311 analyzer) and high-sensitivity troponin-I was measured (Abbot, Architect i1000SR). Urine was collected for assessment of interleukin (IL)-18 (Quantikine, R&D Systems).
+ Open protocol
+ Expand
4

Quantifying Soluble TNF-alpha and Receptor I

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the commercially available enzyme immunoassay (Quantikine; R&D Systems, Inc., Minneapolis, USA) to measure soluble TNF-alpha (sTNF-alpha) in duplicate. This enzyme immunoassay has a sensitivity of 2.6 pg/mL, an inter-assay coefficient of variation of +16.7%, and an intra-assay coefficient of variation of +8.8%.
Serum sTNF-alpha receptor I (sTNFr-I) levels were determined using a commercially available enzyme-linked immunosorbent assay system (Quantikine; R&D Systems, Inc.). Blood samples were analyzed within 1 week of collection, and serum was stored at −80°C until use.
+ Open protocol
+ Expand
5

Measurement of Cardiac Biomarkers in Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
NT-proBNP was measured with an electrochemiluminescence sandwich immunoassay (Elecsys system 2010®, Roche Diagnostics, Mannheim, Germany). TnT assay was performed with a fourth generation assay (Elecsys 2010®, Roche Diagnostics, Mannheim, Germany).
Blood samples were frozen immediately and stored at −70 °C before measurement of sST2, GDF-15, and OPN. Plasma OPN levels were measured with a sandwich immunoassay by use of a commercially available kit (Quantikine®; R&D Systems, Inc., Minneapolis, MN, USA). Plasma levels of soluble suppression of tumorigenicity 2 (sST2) were determined using a novel high-sensitivity sandwich immunoassay (Presage ST2®; Critical Diagnostics, San Diego, CA, USA). Plasma levels of growth differentiation factor 15 (GDF15) were determined by a sandwich enzyme immunoassay technique (Quantikine®; R&D Systems, Inc., Minneapolis, MN, USA).
+ Open protocol
+ Expand
6

Biomarker Measurements in Fasted Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were collected after a 12 h overnight fast and immediately stored at −70°C. The samples had not been thawed before the present measurements. Fasting glucose, insulin, and blood lipids were determined by standard methods in the certified clinical chemistry laboratory of the University Hospital. Insulin resistance was estimated by homeostasis model assessment index. The N‐terminal pro‐brain natriuretic peptide levels were determined by a standard chemiluminescence immunoassay (Roche Diagnostics, Mannheim, Germany). Activin A levels were determined by enzyme‐linked immunosorbent assay (Quantikine, R&D Systems Europe, Wiesbaden‐Nordenstadt, Germany) and were performed at the Medical Clinic III, Dresden University of Technology, Germany, by investigators that were not aware of patients' characteristics and outcomes. Matrix metalloproteinase 9 (MMP‐9) levels were determined by enzyme‐linked immunosorbent assay (Quantikine, R&D Systems Europe, Abingdon, UK); likewise, adiponectin levels were determined by enzyme‐linked immunoassay (BioVendor GmbH, Heidelberg, Germany).
+ Open protocol
+ Expand
7

Respiratory Syncytial Virus Infection Cytokine Profile

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALF was prepared from RSV-infected and uninfected mice on day 1 and day 5 post-infection. Briefly, BALF was obtained from the mice under anesthesia by instilling 0.8 mL of cold PBS into the lungs and aspirating it from the trachea using a tracheal cannula [15 (link)]. The obtained BALF was centrifuged at 160 × g at 4 °C for 10 min. The supernatant was stored at −80 °C until the use for enzyme-linked immunosorbent assay (ELISA). The levels of IFN-α, IFN-β, IFN-γ, and RANTES (CCL5) in BALF were measured using ELISA kits (VeriKine, PBL Assay Science., Piscataway, NJ, USA; Quantikine, R&D Systems, Inc., Minneapolis, MN, USA; Ready-set-go, eBioscience Inc., San Diego, CA, USA; and Quantikine, R&D Systems, Inc., Minneapolis, MN, USA; respectively) according to the manufacturer’s instructions. The lower limits of detection of the kits are 12.5 pg/mL for IFN-α, 1.89 pg/mL for IFN-β, 15 pg/mL for IFN-γ, and 2 pg/mL for RANTES. The intra- and inter-assay coefficients of variation for the ELISA results were less than 10%.
+ Open protocol
+ Expand
8

Biomarker Assays and Doxycycline Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Doxycycline and biomarker assays are performed on specimens frozen in cryovials labeled with numbers that cannot be linked to PID/Letcode except through the DCC and to individuals in the clinical sites only. We use an ultra high performance liquid chromatography (UPLC) tandem mass spectrometry (MS/MS) method at the University of Maryland School of Pharmacy to measure serum doxycycline levels.
Analysis of hs-CRP will be performed using an immunoturbidimetric latex agglutination method (K-Assay [KAI-060], Kamiya Biomedical Co., Seattle, WA). Serum cotinine will be measured with an ELISA (Calbiotech, Spring Valley, CA). Plasma MMP-9 concentrations will be measured by an ELISA, two-site sandwich method that is commercially available (R & D Systems, Quantikine, DMP900). Interferon-gamma will be measured by a sandwich-type ELISA also (R&D Systems, Quantikine, DMP900).
+ Open protocol
+ Expand
9

Quantifying Serum Biomarkers by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum IL-6 levels were determined for all 1255 biomarker project participants by high-sensitivity enzyme-linked immunosorbent assay (ELISA) (Quantikine, R&D Systems, Minneapolis, MN), with a lower sensitivity of detection at 0.16 pg/mL. All values were quantified in duplicate; any value over 10 pg/mL was re-run with sera diluted to fall on the standard curve. The laboratory intra-assay coefficient of variance (CV) was 4.1% and the inter-assay CV was 12.9% (generated by inclusion of a low and high IL-6 serum pool in each assay). Sandwich ELISA kits were also employed to quantify sIL-6r levels (Quantikine, R&D Systems). Sera were diluted 1:100 so values would fall on the standard reference curve from 7 to 2000 pg/mL. Thus, the effective assay range for sIL-6r was 0.7–200 ng/mL. The intra-assay and inter-assay CVs were 2.0% and 6.9%, respectively. Serum CRP levels were determined for all subjects via particle-enhanced immunonephelometric assay, and high values used as exclusion criteria.
+ Open protocol
+ Expand
10

Quantifying VEGF and sVEGFR-2 in Plasma and Tears

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before analysis, the plasma and tears were thawed at room temperature. The total protein concentrations of VEGF and sVEGFR-2 were determined by commercially available ELISA methods (Human VEGF, Quantikine; R&D Systems, Inc., Minneapolis, MN, USA; Human sVEGFR-2/KDR/Flk-1, Quantikine; R&D Systems, Inc.) according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!